explore -WSS

explore

author：knowledge 2025-09-30 18:43:00 - browse：768

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Nurses recount patients attacks

WSS

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Virtual Event: March of the Biosimilars

AstraZeneca to buy developer of next

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Ask STAT: What do you want to know about ChatGPT in medicine?

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

leisure time

explore

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ask STAT: What do you want to know about ChatGPT in medicine?

Drug repurposing or repositioning? The language matters

Future doctors should be trained to promote social change

Trump demands the U.S. pay no more for drugs than other countries … again

Ask STAT: What do you want to know about ChatGPT in medicine?

The cancer drug shortage isn’t new — and neither are the solutions

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Heart attack and stroke risk calculators need revising

U.K. researchers warn about biases in medical devices, algorithms

entertainment

Methadone treatment changes are coming. Do they go far enough?

Methadone treatment changes are coming. Do they go far enough?

Why we need to separate burnout from moral injury in health care

Why drug prescriptions should include diagnoses

UnitedHealth increases loan offers after Change Healthcare outage

WATCH: Why do fingernails fall off when they're damaged?

hotspot

focus

Wikipedia

hotspot